12471 results for
Refine Your Search
Cruz
Cancer almost killed me, but more importantly, it made me who I am and who I will become. I was diagnosed with acute myeloid leukemia (AML) at Texas C…
Nicolas Nassar
I am an Assistant Professor at Cincinnati Children's Hospital Medical Center. My areas of research interest include drug development and signaling wit…
Overcoming RAS-driven Mechanisms of Resistance in Leukemia
The protein kinase (MAPK) pathway is activated in leukemia and is a hallmark of resistance to therapies. This project uses xenograft models of rela…
Yescarta® Receives U.S. FDA Approval as First CAR T-cell Therapy for Initial Treatment of Relapsed or Refractory Large B-cell Lymphoma (LBCL)
SANTA MONICA, Calif. April , - Kite, a Gilead Company (Nasdaq: GILD), today announced the U.S. Food and Drug Administration (FDA) has approved Yescar…
Mark Hamilton
Dr. Mark Hamilton is a native of Austin Texas. His undergraduate education was at Austin College in Sherman, Texas, where he graduated summa cum laude…
Cell-free DNA analysis of persistent CAR T-cell populations in humans
The focus of this research project is to understand how therapeutic chimeric antigen receptor (CAR) mediate remission of diffuse large lymphomas. I…
Suman Paul
I am an assistant professor of oncology at the Johns Hopkins School of Medicine where I treat patients suffering from leukemias and lymphomas. In my c…
Niclosamide for the Treatment of Relapsed/Refractory Pediatric Acute Myeloid Leukemia
Niclosamide is an FDA approved drug that is well tolerated and acts synergistically with chemotherapy to kill AML cells. We will conduct a Phase I cl…
How One Powerful Philanthropic Competition is Taking the Fight Against Cancer by Storm
How One Powerful Philanthropic Competition is Taking the Fight Against Cancer by Storm
News Release
Christian Steidl
Dr. Steidl is the Research Director of the Centre for Lymphoid Cancer (CLC) at BC Cancer and Professor in the Department of Pathology and Laboratory M…
Manuales
Manuales del sobreviviente Utilice estos Manuales del sobreviviente para recopilar toda la información importante que necesite a lo largo de las etap…
LLS Invests in Solutions to Advance Health Equity
More than $. million awarded through new LLS Equity in Access Research Program
Adenylate Kinase 2-A Novel Therapeutic Target in Multiple Myeloma
We identified the adenine nucleotide regulator AK2 as a selective dependency in multiple myeloma (MM) that is more essential for survival of MM cells …
Suggested Reading You Are So Much More
You Are So Much More: An Inspiration for Children Healing From Illness or Injury by Serena Tejpar Publisher: Loving Healing Press June , , Paperback…
Coffee With LLS: Let’s Talk About COVID
Please note, with the fast developing knowledge on this topic, some recommendations may change as new data emerges. Click here to access the latest LL…
John
After six months of frequent hospital and doctor visits for unexplained fever, weakness, and changes in John's activity and personality, an ultimatum …
Cathy
I decided to call my cancer the “little c” rather than the “Big C.” I wasn't giving it that much power over my life!The year was memorable for all th…
Stephenie
When I was diagnosed with stage 3B Hodgkin lymphoma (HL), I was only years old. The Leukemia & Lymphoma Society (LLS) was one of the first organizati…
Jenna
Nobody ever expects to be diagnosed with cancer at , but that’s exactly what happened to me. It came completely out of the blue. I had zero symptoms. …
Daniel (Lil Sicky)
Cancel blood cancer with web3! Daniel is a - lymphoma patient who combined his medical diagnosis and love of digital art into an NFT project supportin…
%20(1)_dam_file_145201.jpg?crop=true&keep=c&w=400&h=400)
Matthew
Our Matthew was first diagnosed with acute lymphoblastic leukemia (ALL) in August at the age of . He relapsed with ALL in December and underwent his…
AJ
On December , , our lives changed forever. And sadly, it was just the beginning.I was assigned to work a night shift an hour away from where I dropped…
Simantinee
It started when I was in my second year of studying engineering with a small lump on my neck. Dad's suspicion got me to the procedure room the next mo…
Dylan
I was diagnosed with acute lymphoblastic leukemia (ALL) the summer of , right before the start of my junior year in high school. Due to slow immune re…
LLS Appoints Chief People Officer
We are delighted to share that, effective immediately, Dale Nissenbaum has been formally appointed as The Leukemia & Lymphoma Society’s (LLS) Chief Pe…
News Release